BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35384806)

  • 1. Stereotactic Ablative Body Radiotherapy as a Bridge to Liver Transplant for Hepatocellular Carcinoma: Preliminary Results of Başkent University Experience.
    Yavas G; Ayvazoglu Soy EH; Coskun M; Onal C; Boyvat F; Haberal M
    Exp Clin Transplant; 2022 Mar; 20(Suppl 1):39-45. PubMed ID: 35384806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies.
    Kimura T; Aikata H; Doi Y; Imano N; Takeuchi Y; Takahashi I; Nishibuchi I; Katsuta T; Kenjo M; Murakami Y; Awai K; Chayama K; Nagata Y
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818783450. PubMed ID: 29963972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor response on CT following hypofractionated stereotactic ablative body radiotherapy for small hypervascular hepatocellular carcinoma with cirrhosis.
    Sanuki N; Takeda A; Mizuno T; Oku Y; Eriguchi T; Iwabuchi S; Kunieda E
    AJR Am J Roentgenol; 2013 Dec; 201(6):W812-20. PubMed ID: 24261388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic ablative radiation therapy prior to liver transplantation in hepatocellular carcinoma.
    Guarneri A; Franco P; Romagnoli R; Trino E; Mirabella S; Molinaro L; Rizza G; Filippi AR; Carucci P; Salizzoni M; Ricardi U
    Radiol Med; 2016 Nov; 121(11):873-881. PubMed ID: 27447803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma.
    Takeda A; Sanuki N; Eriguchi T; Kobayashi T; Iwabutchi S; Matsunaga K; Mizuno T; Yashiro K; Nisimura S; Kunieda E
    J Gastroenterol Hepatol; 2014 Feb; 29(2):372-9. PubMed ID: 23927053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of the safety and efficacy of liver stereotactic body radiotherapy in patients with and without prior liver-directed therapy.
    Moon DH; Wang AZ; Tepper JE
    Radiother Oncol; 2018 Mar; 126(3):527-533. PubMed ID: 29366521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiotherapy of the liver: a bridge to transplantation stereotactic radiotherapy of the liver: a bridge to transplantation.
    Al Hamad AA; Hassanain M; Michel RP; Metrakos P; Roberge D
    Technol Cancer Res Treat; 2009 Dec; 8(6):401-5. PubMed ID: 19925023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic hypofractionated radiation therapy as a bridge to transplantation for hepatocellular carcinoma: clinical outcome and pathologic correlation.
    Katz AW; Chawla S; Qu Z; Kashyap R; Milano MT; Hezel AF
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):895-900. PubMed ID: 22172906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Addition of Ablative Therapy Following Transarterial Chemoembolization With Survival Rates in Patients With Hepatocellular Carcinoma.
    English K; Brodin NP; Shankar V; Zhu S; Ohri N; Golowa YS; Cynamon J; Bellemare S; Kaubisch A; Kinkhabwala M; Kalnicki S; Garg MK; Guha C; Kabarriti R
    JAMA Netw Open; 2020 Nov; 3(11):e2023942. PubMed ID: 33151315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image-guided stereotactic ablative radiotherapy for the liver: a safe and effective treatment.
    Van De Voorde L; Vanneste B; Houben R; Damen P; van den Bogaard J; Lammering G; Dejong K; de Vos-Geelen J; Buijsen J; Öllers M; Berbée M; Lambin P
    Eur J Surg Oncol; 2015 Feb; 41(2):249-56. PubMed ID: 25468743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma.
    Paik EK; Kim MS; Jang WI; Seo YS; Cho CK; Yoo HJ; Han CJ; Park SC; Kim SB; Kim YH
    Radiat Oncol; 2016 Feb; 11():22. PubMed ID: 26896371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Toxicity of Stereotactic Body Radiotherapy for Early to Advanced Stage Hepatocellular Carcinoma - Initial Experience From an Australian Liver Cancer Service.
    Liu HY; Lee Y; McLean K; Leggett D; Hodgkinson P; Fawcett J; Mott R; Stuart K; Pryor D
    Clin Oncol (R Coll Radiol); 2020 Oct; 32(10):e194-e202. PubMed ID: 32345457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approach.
    Boldrini L; Romano A; Mariani S; Cusumano D; Catucci F; Placidi L; Mattiucci GC; Chiloiro G; Cellini F; Gambacorta MA; Indovina L; Valentini V
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):2057-2068. PubMed ID: 33398447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of external beam radiotherapy complementing incomplete transarterial chemoembolization for hepatocellular carcinoma.
    Park S; Yoon WS; Jang MH; Rim CH
    Int J Radiat Biol; 2020 Dec; 96(12):1541-1549. PubMed ID: 32990486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic ablative radiotherapy in the treatment of hepatocellular carcinoma >3 cm.
    Guarneri A; Franco P; Trino E; Campion D; Faletti R; Mirabella S; Gaia S; Ragona R; Diotallevi M; Saracco G; Salizzoni M; Ricardi U; Carucci P
    Med Oncol; 2016 Oct; 33(10):104. PubMed ID: 27566310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of localized hepatocellular carcinoma: resection vs. ablation vs. radiation.
    Anderson C; Chin HM; Hoverson J; Court C; Wagner T; Newman NB
    Ann Palliat Med; 2024 Mar; 13(2):344-354. PubMed ID: 38373778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiotherapy in patients with hepatocellular carcinoma in a multimodal treatment setting.
    Gerum S; Heinz C; Belka C; Walter F; Paprottka PM; De Toni EN; Roeder F
    Strahlenther Onkol; 2020 Apr; 196(4):334-348. PubMed ID: 31732784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma.
    Saviano A; Iezzi R; Giuliante F; Salvatore L; Mele C; Posa A; Ardito F; De Gaetano AM; Pompili M;
    J Vasc Interv Radiol; 2017 Nov; 28(11):1512-1519. PubMed ID: 28734848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant.
    Wong TC; Lee VH; Law AL; Pang HH; Lam KO; Lau V; Cui TY; Fong AS; Lee SW; Wong EC; Dai JW; Chan AC; Cheung TT; Fung JY; Yeung RM; Luk MY; Leung TW; Lo CM
    Hepatology; 2021 Nov; 74(5):2580-2594. PubMed ID: 34091914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.